106021-96-9 ((L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-)

CAS号:
106021-96-9
英文名称:
L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-
分子式:
C39H64N12O19
分子量:
1004.99446964264

L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-(106021-96-9)名称与标识符

名称

英文别名:
L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-;[beta]-Interleukin I (163-171), human;beta-Interleukin I (163-171), human;H-VAL-GLN-GLY-GLU-GLU-SER-ASN-ASP-LYS-OH;IL-1β (163-171) (human);IL-1β (163-171) (human), Interleukin-1β (163-171) (human);L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspart...;VAL-GLN-GLY-GLU-GLU-SER-ASN-ASP-LYS;b-Interleukin I (163-171), human;IL-1B (163-171) (HUMAN);IL-1BETA (163-171) (HUMAN);INTERLEUKIN-1B (163-171) (HUMAN);INTERLEUKIN-1BETA (163-171) (HUMAN);β-INTERLEUKIN I (163-171), HUMAN;interleukin-1beta(163-171;interleukin-1β fragment 163-171 human;NCGC00167209-01;CS-0063273;(2S)-6-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]hexanoic acid;SCHEMBL6856783;Interleukin 1-beta (163-171);106021-96-9;-Interleukin I (163-171), human;L-valyl-L-glutaminylglycyl-L-glutamyl-L-glutamyl-L-seryl-L-asparaginyl-L-aspartyl-L-lysine;IL-1beta (163-171);Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-OH;L-Lysine, N2-(N-(N2-(N-(N-(N-(N-(N2-L-valyl-L-glutaminyl)glycyl)-L-alph-glutamyl)-L-alpha-glutamyl)-L-seryl)-L-asparaginyl)-L-alpha-aspartyl)-;interleukin-1beta (163-171);HY-113893;

标识符

InChIKey:
NIXBZDOQHRZFDR-OEWCNXHOSA-N
Inchi:
1S/C39H64N12O19/c1-17(2)31(43)38(68)47-18(6-9-25(41)53)32(62)44-15-27(55)45-19(7-10-28(56)57)33(63)46-20(8-11-29(58)59)34(64)51-24(16-52)37(67)49-22(13-26(42)54)35(65)50-23(14-30(60)61)36(66)48-21(39(69)70)5-3-4-12-40/h17-24,31,52H,3-16,40,43H2,1-2H3,(H2,41,53)(H2,42,54)(H,44,62)(H,45,55)(H,46,63)(H,47,68)(H,48,66)(H,49,67)(H,50,65)(H,51,64)(H,56,57)(H,58,59)(H,60,61)(H,69,70)/t18-,19-,20-,21-,22-,23-,24-,31-/m0/s1
SMILES:
O=C([C@H](CCC(=O)O)NC(CNC([C@H](CCC(N)=O)NC([C@H](C(C)C)N)=O)=O)=O)N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(=O)O)C(N[C@H](C(=O)O)CCCCN)=O)=O)=O)=O)CCC(=O)O

L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-(106021-96-9)物化性质

实验特性

  • LogP : -2.04100
  • PSA : 540.45000

计算特性

  • 精确分子量 : 1004.44000
  • 氢键供体数量 : 17
  • 氢键受体数量 : 31
  • 可旋转化学键数量 : 44
  • 同位素质量 : 1004.44106786g/mol
  • 重原子数量 : 70
  • 复杂度 : 1920
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 8
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -12.6
  • 拓扑分子极性表面积 : 540Ų

L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-(106021-96-9)安全信息

L-Lysine,L-valyl-L-glutaminylglycyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-asparaginyl-L-a-aspartyl-(106021-96-9)推荐厂家 更多厂家(10)